20 LATEST RESOURCES (233 INDEXED)
Impacts of Metabolic Disruption, Body Mass Index and Inflammation on Cognitive Function in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine · February 2024
Articles
Annals of General Psychiatry
Predicting Antipsychotic-Induced Weight Gain in First Episode Psychosis – A Field-Wide Systematic Review and Meta-Analysis of Non-Genetic Prognostic Factors · June 2023
Articles
European Psychiatry
Weight Gain is Not Associated with Antipsychotic Medication, Sociodemographic Factors, or Diagnosis in a Welsh Secure Mental Health Unit · June 2023
Articles
International Journal of Forensic Mental Health
Comparison of Olanzapine-Induced Weight Gain and Metabolism Abnormalities between Topiramate and Vitamin C in Patients with Schizophrenia: A Preliminary Study · May 2023
Articles
Frontiers in Psychiatry
Plasma Concentrations of SSRI/SNRI After Bariatric Surgery and the Effects on Depressive Symptoms · April 2023
Articles
Frontiers in Psychiatry
Metabolic Biomarkers of Risperidone-Induced Weight Gain in Drug-Naive Patients with Schizophrenia · April 2023
Articles
Frontiers in Psychiatry
Olanzapine and Weight Loss in Early-Onset Schizophrenia · April 2023
Articles
Primary Care Companion for CNS Disorders
Association of Antipsychotic-Related Weight Gain with Treatment Adherence and Switching Using Electronic Medical Records Data · March 2023
Articles
Primary Care Companion for CNS Disorders
Association between Antipsychotic Medication and Clinically Relevant Weight Change: Meta-Analysis · January 2023
Articles
BJPsych Open
Olanzapine/Samidorphan Combination Consistently Mitigates Weight Gain Across Various Subgroups of Patients · October 2022
Articles
CNS Spectrums
Varenicline and Lorcaserin for Smoking Cessation and Weight Gain Prevention: A Randomized Clinical Trial · September 2022
Articles
Mayo Clinic Proceedings: Innovations, Quality and Outcomes
A Systematic Review of Clinical Trials on Lumateperone and Its Effects on Body Weight · September 2022
Abstracts
Journal of Clinical Psychopharmacology
Antioxidant Enzymes and Weight Gain in Drug-Naive First-Episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study · August 2022
Articles
NCBI>Current Neuropharmacology
The Relationship between Early Weight Loss and Weight Loss Maintenance with Naltrexone-Bupropion Therapy · May 2022
Articles
eClinicalMedicine
Probiotics Plus Dietary Fiber Supplements Attenuate Olanzapine-Induced Weight Gain in Drug-Naive First-Episode Schizophrenia Patients: Two Randomized Clinical Trials · May 2022
Articles
Schizophrenia Bulletin
Opioid Antagonism Mitigates Antipsychotic-Associated Weight Gain: Focus on Olanzapine · March 2022
Articles
CNS Spectrums
Antipsychotic-Induced Weight Gain: Dose-Response Meta-Analysis of Randomized Controlled Trials · February 2022
Articles
Schizophrenia Bulletin
Twenty-Four Week, Randomized, Double-Blind, Placebo-Controlled Trial of Metformin for Antipsychotic-Induced Weight Gain in Patients with First-Episode Psychosis: A Pilot Study · December 2021
Articles
International Journal of Environmental Research and Public Health
A Double-Blind, Placebo-Controlled Trial of Bupropion Add-On to Olanzapine or Risperidone in Overweight Individuals with Schizophrenia · November 2021
Abstracts
Journal of Clinical Psychopharmacology